October 20, 2021
Rose
The drug, Aduhelm, brought in $300,000 in revenue in its first full three months of availability. The company expects the drug to generate minimal revenue for the rest of the year.
from NYT > Health https://ift.tt/3nbgvdl
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment